Jesper Roested

Chief Executive Officer, TJCC ApS

Olesvej 142 active roles

Jesper Roested holds 2 active roles in Danish companies registered in CVR, including Chief Executive Officer at TJCC ApS since 2025 and Management at ROESTED PARTNERS ApS since 2009. Jesper Roested is registered as legal owner of ROESTED PARTNERS ApS (100% share band). 14 earlier roles have ended, the most recent in 2024.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2025 – now
Chief Executive Officer, TJCC ApS
2018 – 2024
Chief Executive Officer, Subcuject ApS
2018
Chairman, FreeSense ApS
2016 – 2018
Board of Directors, OPERATOR SYSTEMS A/S
2015 – 2018
Board of Directors, OBI ApS
2013 – 2018
Board of Directors, NANOVI A/S
2013 – 2014
Board of Directors, CAPEVO A/S
2013 – 2014
Board of Directors, Selskabet af 22. juni 2016 ApS
2012 – 2015
Board of Directors, MICROLYTIC ApS
2012
Board of Directors, FLUXOME SCIENCES A/S
2011 – 2015
Board of Directors, EXPRES2ION BIOTECHNOLOGIES ApS
2011 – 2014
Board of Directors, AKTIESELSKABET AF 1. FEBRUAR 2013
2011 – 2012
Board of Directors, ENTOMOPHARM ApS
2011
Management, DRUGMODE ApS
2009 – now
Management, ROESTED PARTNERS ApS
2005 – 2009
Management, DDD-DIAGNOSTIC A/S

Personal details

Address

Olesvej 14

Companies & roles

Active roles

2 positions

Company	Role	Period	Ownership	Status
ROESTED PARTNERS ApS CVR 32095542	ManagementManagement	Since 2009	100%	Active
TJCC ApS CVR 44888092	ManagementChief Executive Officer	Since 2025	—	Active

Historical roles

14 positions

Company	Role	Period	Ownership	Status
EXPRES2ION BIOTECHNOLOGIES ApS CVR 32770487	BoardBoard of Directors	2011 – 2015	—	Active
OPERATOR SYSTEMS A/S CVR 27957277	BoardBoard of Directors	2016 – 2018	—	Active
FLUXOME SCIENCES A/S CVR 26446171	BoardBoard of Directors	2012 – 2012	—	Dissolved
OBI ApS CVR 26630606	BoardBoard of Directors	2015 – 2018	—	Dissolved
AKTIESELSKABET AF 1. FEBRUAR 2013 CVR 27297080	BoardBoard of Directors	2011 – 2014	—	Dissolved
MICROLYTIC ApS CVR 29536163	BoardBoard of Directors	2012 – 2015	—	Dissolved
DRUGMODE ApS CVR 29600937	ManagementManagement	2011 – 2011	—	Dissolved
CAPEVO A/S CVR 30280024	BoardBoard of Directors	2013 – 2014	—	Dissolved
ENTOMOPHARM ApS CVR 32070108	BoardBoard of Directors	2011 – 2012	—	Dissolved
Selskabet af 22. juni 2016 ApS CVR 33370490	BoardBoard of Directors	2013 – 2014	—	Dissolved
FreeSense ApS CVR 37268941	BoardChairman	2018 – 2018	—	Dissolved
Subcuject ApS CVR 38349279	ManagementChief Executive Officer	2018 – 2024	—	Dissolved
NANOVI A/S CVR 34889031	BoardBoard of Directors	2013 – 2018	—	Active
DDD-DIAGNOSTIC A/S CVR 11296645	ManagementManagement	2005 – 2009	—	Dissolved

1 company dissolved after bankruptcy or enforced closure where the role ended within the last 5 years

Subcuject ApS

CVR 38349279 · Dissolved after bankruptcy · role ended 2024

Role: Chief Executive Officer

Network

Company network

Active roles

Jesper Roested

ROESTED PARTNERS ApS

Management

TJCC ApS

Chief Executive Officer

Past companies

EXPRES2ION BIOTECHNOLOGIES ApS OPERATOR SYSTEMS A/S FLUXOME SCIENCES A/S OBI ApS AKTIESELSKABET AF 1. FEBRUAR 2013 MICROLYTIC ApS DRUGMODE ApS CAPEVO A/S ENTOMOPHARM ApS Selskabet af 22. juni 2016 ApS FreeSense ApS Subcuject ApS NANOVI A/S DDD-DIAGNOSTIC A/S

Co-directors & shared companies

No shared company connections found.

Is this you? About the data on this page

This profile is compiled automatically from CVR / Virk, the official business register in Denmark. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.